PMID,Title,Journal,Year
39999241,,,2025
39079992,"Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial.",Nature medicine,2024
38542454,"A Breakthrough in the Treatment of Necrobiosis Lipoidica? Update on Treatment, Etiopathogenesis, Diagnosis, and Clinical Presentation.",International journal of molecular sciences,2024
38275036,Future is Brighter: New Potential Paradigm-Shifting Medications and Regimens for Diabetes and Obesity.,Current diabetes reviews,2024
35072168,A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes.,Immunotherapy advances,2022
34663658,"Phase II multicentre, double-blind, randomised trial of ustekinumab in adolescents with new-onset type 1 diabetes (USTEK1D): trial protocol.",BMJ open,2021
30730852,Treg gene signatures predict and measure type 1 diabetes trajectory.,JCI insight,2019
24947953,Targeting the IL-17/IFN-gamma axis as a potential new clinical therapy for type 1 diabetes.,"Clinical immunology (Orlando, Fla.)",2014
